Abstract:Objective Lidamycin, an enediyne antibiotic, leads to apoptosis and mitotic cell death of human tumor cells at high and low concentrations. The reason why tumor cells have distinct responses to lidamycin remains elusive. This study was to elucidate if cellular prosurvival molecules are involved in these responses. Methods Cleavage of chromatin and DNA was observed by chromatin condensation and agarose gel electrophoresis. Accumulation of rhodamine 123 in lidamycin-treated cells was assayed by flow cytometry. Cell multinucleation was detected by staining with Hoechst 33342. Western blot and senescence-associated beta-galactosidase (SA-beta-gal) staining were used to analyze protein expression and senescence-like phenotype, respectively. Results SIRT1 deacetylase remained unchanged in 0.5 nmol/L lidamycin whereas cleavage occurred when apoptosis was induced by lidamycin. Increased FOX03a, SOD-1 and SOD-2 expression and transient phosphorylation of ERK were detected after exposure of human hepatoma BEL-7402 cells to 0.5 nmol/L lidamycin. High expressions of SIRT1 and Akt were found in colon carcinoma HCT116 p53 knock-out cells exposed to lidamycin. Degradation of PARP and p53 by lidamycin as a substitute for SIRT1 and Akt was confirmed with caspase inhibitor Q-VD-OPh and proteasome inhibitor MG132. Resistance to lidamycin-induced DNA cleavage was observed in breast cancer doxorubicin-resistant MCF-7 cells. This was not induced by P-glycoprotein as no accumulation of rhodamine 123 was detected in the resistant cells following exposure to lidamycin. In contrast to sensitive MCF-7 cells, a lower multinucleation rate for the resistant cells was measured following exposure to equal concentrations of lidamycin. Conclusions Cellular prosurvival molecules, such as SIRT1, Akt, SOD-1, SOD-2 and other unknown factors can influence the action of lidamycin on human tumor cells.

Role of Prosurvival Molecules in the Action of Lidamycin Toward Human Tumor Cells

P53 Dependent and Independent Apoptosis Induced by Lidamycin in Human Colorectal Cancer Cells

Amide-linked local anesthetics induce apoptosis in human non-small cell lung cancer.

Difference of mitotic cell death induced by lidamycin in human hepatoma cells and normal liver cells

Inhibitory Effect of Low-Dose Lidamycin on Growth of P19 Embryonal Carcinoma Cells and Its Mechanism

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Liriopesides B Induces Apoptosis and Cell Cycle Arrest in Human Non‑small Cell Lung Cancer Cells.

Lidamycin Induces Neural Differentiation of Mouse Embryonic Carcinoma Cells Through Down-Regulation of Transcription Factor Oct4.

Inhibition of Mouse Embryonic Carcinoma Cell Growth by Lidamycin Through Down-Regulation of Embryonic Stem Cell-Like Genes Oct4, Sox2 and Myc

The Use of Mitochondrial Targeting Resveratrol Liposomes Modified with a Dequalinium Polyethylene Glycol-Distearoylphosphatidyl Ethanolamine Conjugate to Induce Apoptosis in Resistant Lung Cancer Cells

Microbial Lipopeptide Supramolecular Self-Assemblies as a Methuosis-Like Cell Death Inducer with In Vivo Antitumor Activity

Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin

The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells.

Lidamycin induces mitophagy in pancreatic cancer cells by regulating the expression of Mfn2

Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies.

Role of Apoptosis Inhibition in the Multidrug Resistance of the Human Lung Adenocarcinoma Cell Line SPC-A1/Docetaxel

A Study on the Mechanism of Adriamycin-Induced Apoptosis of Human Hepatic Carcinoma Cells

Structure-activity Relationships OF N-methylthiolated Beta-Lactam Antibiotics with C3 Substitutions and Their Selective Induction of Apoptosis in Human Cancer Cells.

Saponin and Ribosome-Inactivating Protein Synergistically Trigger Lysosome-Dependent Apoptosis by Inhibiting Lysophagy: Potential to Become a New Antitumor Strategy

Riccardin D-N Induces Lysosomal Membrane Permeabilization by Inhibiting Acid Sphingomyelinase and Interfering with Sphingomyelin Metabolism in Vivo.

[Inhibitory and Apoptosis Regulating Effects of Adriamycin on Different Human Breast Cancer Cell Lines].